The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice

Polish Journal of Veterinary Sciences

Volumn 11, Issue 2, 2008, Pages 97-104

  Skopinska Rozewska E ^a   Malinowski, M ^a   Wasiutynski A ^a   Sommer, E ^a   Furmanowa, M ^a   Mazurkiewicz, M ^a   Siwicki, A K ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Angiogenesis; Mice; Rhodiola quadrifida; Tumor cells

Indexed keywords

GLUCOSIDE; PHENOL DERIVATIVE; PLANT EXTRACT; RHODIOLOSIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DOSE RESPONSE; FEMALE; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYTOTHERAPY; RANDOMIZATION; RHODIOLA; SKIN TUMOR;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSIDES; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RHODIOLA; SKIN NEOPLASMS;

CRASSULACEAE; MUS; RHODIOLA; RHODIOLA ROSEA;

EID: 44449116049     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: Biologic mechanisms and practical implications. Nutr Rev 57: 78-83.
2. Aoki M, Kanamori M, Yudoh K, Ohmori K, Yasuda T, Kimura T (2001) Effects of vascular endothelial growth factor and E-selectin on angiogenesis in the murine metastatic RCT sarcoma. Tumor Biol 22: 239-246.
3. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: 365-371.
4. Bałan BJ, Skopińska-Różewska E, Barcz E, Sokolnicka I, Gawrychowski K, Strzelecka H (1999) The effect of selected phenolic acids on angiogenic activity of ovarian cancer cells- preliminary report. Onkol Pol 2: 203-208.
5. Bałan BJ, Skopińska-Różewska E, Domański J, Skurzak H, Snitkowska E, Sommer E (2001) Assessment of anti-angiogenic activity of multicomponent herbal preparation "Pervivo" using digital computer image analysis. Terapia IX (3/2) : 21-22.
6. Balasubramanian L, Evens AM (2006) Targeting angiogenesis for the treatment of sarcoma. Curr Opin Oncol 18: 354-359.
7. Bany J, Skopińska-Różewska E, Chorostowska-Wynimko J, Rogala E, Sommer E, Zdanowska D, Filewska M, Skurzak H (2004) The effect of complex herbal remedy on the angiogenic activity of L-1 sarcoma cells, L-1 sarcoma tumor growth, and on the bacterial infection in mice. Centr Eur J Immunol 29: 29-34.
8. Barcz E, Sommer E, Janik P, Marianowski L, Skopińska- Różewska E (2000) Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncology Reports 7: 1285-1291.
9. Bocharova OA, Matweev BP, Baryshnikov AI, Figurin KM, Serebriakova RV, Bodrova NB (1995) The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer. Urol Nefrol (Mosk) 2: 46-47.
10. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69: 4-10.
11. Chung S Yang, Jee Y Chung, Guang-yu Yang, Saranjit K Chhabra, Mao-Jung Lee (2000) Tea and tea polyphenols in cancer prevention. J Nutr 130: 472-478.
12. Demeule M, Brossard M, Page M, Gingras D, Béliveau R (2000) Matrix metalloproteinase inhibition by green tea catechins. Biochem Biophys Acta 1478: 51-60.
13. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR (1995) Vascular permeability factor vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107: 233-235.
14. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Seminars in Oncology 29: 15-18.
15. Folkman J (2003) Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther 2: 127-133.
16. Gasparini G (1999) The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 58: 17-38.
17. Gil M, Skopińska-Różewska E, Radomska D, Demkow U, Skurzak H, Rochowska M, Beuth J, Roszkowski K (1993) Effect of purinergic receptor antagonists Suramin and Theobromine on tumor-induced angiogenesis in Balb/c mice. Folia Biologica 39: 63-68.
18. Hoser G, Furmanowa M, Urbańska N, Pietrosiuk A, Zobel A, Kuraś M (2006) Antiproliferative and antimitotic effect, S phase accumulation and induction of apoptosis and necrosis after treatment of extract from Rhodiola rosea rhizomes on HL-60 cells. J Ethnopharmacol 103: 43-52.
19. Kamiński MJ, Bem W, Majewski S, Kamińska G, Szmurlo A (1981) Angiogenesis induction by xenogenic lymphoid and non-lymphoid cells in mice. Arch Immunol Ther Exp 29: 521-523.
20. Kim S, Lee MJ, Hong J, Li C, Smith TJ, Yang GY, Seril DN, Yang CS (2000) Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 37: 41-48.
21. Kimura I (2006) Medical benefits of using natural compounds and their derivatives having multiple pharmacological actions. Yakugaku Zasshi 126: 133-143.
22. Kucinskaite A, Briedis V, Savickas A (2004) Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina 40: 614-19.
23. Lambert JD, Churug SY (2003) Cancer chemopreventive activity and bioavailability of tea polyphenols. Mutation Res 523-524: 201-208.
24. Maeda-Yamamoto M, Kawahara H, Tahara N, Tsuji K, Hara Y, Isemura M (1999) Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcona HT1080 cells. J Agric Food Chem 47: 2350-2354.
25. Malonne H, Langer I, Kiss R, Atassi G (1999) Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors. Clin Exp Metastasis 17: 1-14.
26. Milkiewicz M, Ispanovic E, Doyle JL, Haas TL (2006) Regulators of angiogenesis and strategies for their therapeutic regulation. Int J Biochem Cell Biol 38: 333-357.
27. Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH (2005) Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 19: 740-743.
28. Nartowska J, Sommer E, Siwicki AK, Bany J, Skurzak H, Augustynowicz J, Skopińska-Różewska E (2005) The anti-angiogenic and immunotropic properties of convallamaroside, a steroidal saponin isolated from rhizomes and roots of Convallaria majalis L. Pol J Environ Stud 14: 296-299.
29. Razina TG, Zueva EP, Amosova EN, Krylova SG (2000) Medicinal plant preparations used as adjuvant therapeutics in experimental oncology. Eksp Klin Farmakol 63: 59-61.
30. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, Ellis L, Liu W, Go VL, Brooks MN (2002) Green tea inhibits vascular endothelial growth factors (VEGF) induction in human breast cancer cells. J Nutr 132: 2307-2311.
31. Sidky YA, Auerbach R (1975) Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med 141: 1084-1100.
32. Siemeister G, Martiny-Baron G, Marmé D (1998) The pivotal role of VEGF in tumor angiogenesis: Molecular facts and therapeutic opportunities. Cancer Metastasis Rev 17: 241-248.
33. Siwicki AK, Skopińska-Różewska E, Nartowska J, Malaczewska J, Wójcik R, Sommer E, Trapkowska S, Filewska M, Skurzak H (2004) Effect of Immunostim Plus - a standarized fixed combination of Schizandra chinensis with Eleutherococcus Senticosus extracts on granulocyte activity and tumor angiogenesis in mice. Bull Vet Inst Pulawy 48: 489-492.
34. Siwicki AK, Skopińska-Różewska E, Hartwich M, Wójcik R, Bakuła T, Furmanowa M, Bałan BJ, Sommer E, Mielcarek S, Buchwald W, Krajewska-Patan A, Mścisz A, Mrozikiewicz PM, Bany J (2007) The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur J Immunol 32: 84-91.
35. Skopińska-Różewska E, Sommer E, Bałan BJ, Skopiński P, Demkow U (1995) Methyloxantines as angiogenesis inhibitors. International J Oncol 7(Suppl): 949.
36. Skopińska-Rózewska E, Sommer E, Demkow U, Chorostowska-Wynimko J, Bałan B, Rózycka B, Barcz E, Filewska M, Mlekodaj S, Rudziński P, Seweryniak W, Caban P, Kupis W, Bogdan J, Usiekniewicz P, Gatarek J, Langfort R (1997) Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer. Roczniki Akademii Medycznej w Białymstoku 42: 287-296.
37. Skopińska-Rózewska E, Piazza GA, Sommer E, Pamukcu R, Barcz E, Filewska M, Kupis W, Caban R, Rudziński P, Bogdan J, Mlekodaj S, Sikorska E (1998a) Inhibition of angiogenesis by Sulindac and its sulfone metabolite (FGN-1): A potential mechanism for their antineoplastic properties. Int J Tissue React 20: 85-89.
38. Skopinska-Rózewska E, Janik P, Przybyszewska M, Sommer E, Bialas-Chromiec B (1998b) Inhibitory effect of Theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. Int J Mol Med 2: 649-652.
39. Skopinska-Rózewska E, Krotkiewski M, Sommer E, Rogala E, Filewska M, Bialas-Chromiec B, Pastewka K, Skurzak H (1999) Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumor cells. Oncol Rep 6: 1341-1344.
40. Skopińska-Rózewska E, Chorostowska-Wynimko J, Krotkiewski M, Rogala E, Sommer E, Demkow U, Skurzak H (2003) Inhibitory effect of Greenland Shark Liver Oil combined with Squalen and Arctic birch ashes on angiogenesis and L-1 Sarcoma growth in Balb/c mice. Pol J Vet Sci 6: 54-56.
41. Skopińska-Różewska E, Nartowska J, Wojtasik E, Sommer E, Bałan BJ, Bany J, Demkow U, Skopiński P, Siwicki AK, Mierzwińska E, Demkow T, Skurzak H, Pastewka K, Białas-Chromiec B, Filewska M, Matczak A (2006) Poszukiwanie inhibitorów angiogenezy nowotworowej wśród leków naturalnych o właśnosciach immunomoduluja̧cych. In: Siwicki AK, Skopińska-Róz̈ewska E (ed) Naturalne i syntetyczne modulatory odpowiedzi immunologicznej i angiogenezy. SPW EDYCJA Publishers, Olsztyn, pp 7-26.
42. Skopińska-Różewska E, Skurzak H, Wasiutyński A, Jung L, Siwicki AK, Bałan BJ, Sommer E, Mazurkiewicz M, Skorupski M, Pra̧tnicki A, Sokolnicka I, Skopiński P (2007) Sarcoma L-1 in mice as a model for the study of experimental angiogenesis. Centr Eur J Immunol 32: 77-83.
43. Skopińska-Różewska E, Hartwich M, Siwicki A, Wasiutyński A, Sommer E, Mazurkiewicz M, Bany J, Skurzak H (2008) The influence of Rhodiola rosea extracts and rosavin on cutaneous angiogenesis induced in mice by grafting of syngeneic tumor cells. Centr Eur J Immunol 33(3): 102-107.
44. Skopinski P, Szaflik J, Duda-Król B, Nartowska J, Sommer E, Chorostowska-Wynimko J Demkow U, Skopińska-Różewska E (2004) Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Molecular Medicine 14: 707-711.
45. Skopiński P, Skopińska-Różewska E, Sommer E, Siwicki AK, Wasiutyński A (2005) The effect of some diet-derived angiogenesis inhibitors and sulindac sulfone on the ability of VEGF, bFGF and IL-18 to induce cutaneous neo-vascular response in mice. Pol J Environ Stud 14 (Suppl 2): 325-329.
46. Sommer E, Skopińska-Różewska E, Skurzak H (2001) The effect of linoleic acid on the growth and vascularity of L-1 sarcoma in mice and on the cutaneous angiogenesis induced by tumor cells. Współczesna Onkologia 5: 250-253.
47. Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A (2002) MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16: 555-564.
48. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H (1999) Synergistic effects of epigallocatechin gallate with epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 59: 44-47.
49. Sui XL, Yang F, Chen RH, Ga B, Yan H, Zhang SF, Zhang JL (2006) Inhibition of Rhodiola on the growth of EVC-304 cell line. XI Bao Yu Fen Zi Mian Yi Xue Za Zhi 22: 524-525.
50. Thompson WD, Li WW, Maragoudakis M (1999) The clinical manipulation of angiogenesis: pathology, side effects, surprises and opportunities with novel human therapies. J Pathol 187: 503-510.
51. Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA (2004) Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19: 245-263.
52. Wasiutyński A, Siwicki AK, Bałan BJ, Sommer E, Bany J, Wa̧sik M, Pra̧tnicki A, Skurzak H, Skopińska- Różewska E (2005) Inhibitory effect of cocoa catechins on embryonic and tumor angiogenesis in mice. Pol J Environ Stud 14 (Suppl 2): 800-805.
53. Wasiutyński A, Skopińska-Różewska E, Jung L, Sommer E, Bany J, Siwicki AK, Chorostowska-Wynimko J, Pra̧tnicki A, Morton M, Skurzak H (2006) Comparison of the effects of Enoxaparin and Nadroparin on tumor angiogenesis in mice. Centr Eur J Immunol 31: 70-74.
54. Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M, Narantuya S (2007) Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 4: 308-311.